Filter Results:
(488)
Show Results For
- All HBS Web
(488)
- People (1)
- News (152)
- Research (274)
- Events (3)
- Multimedia (3)
- Faculty Publications (94)
Show Results For
- All HBS Web
(488)
- People (1)
- News (152)
- Research (274)
- Events (3)
- Multimedia (3)
- Faculty Publications (94)
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
understanding the lack of diversity in entrepreneurship and the venture capital industry. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=52704 Cellophane, the New Visuality, and the... View Details
Keywords: Sean Silverthorne
- May 2016 (Revised March 2020)
- Teaching Note
Cyberdyne: A Leap to the Future
By: Doug J. Chung and Mayuka Yamazaki
Cyberdyne Inc. was a Japanese technology venture founded in 2004 by scientist Yoshiyuki Sankai to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from... View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
https://www.hbs.edu/faculty/Pages/item.aspx?num=52673 Harvard Business School Case 517-050 Beingmate Founded in 2002, Hangzhou, China–based Beingmate was a major producer of infant formula and related products in the high-demand Chinese... View Details
Keywords: Carmen Nobel
- 12 Feb 2014
- News
A decidedly mixed bag
- 06 Mar 2018
- First Look
First Look at Research and Ideas, March 6, 2018
https://www.hbs.edu/faculty/Pages/item.aspx?num=52341 February 20, 2018 JAMA, the Journal of the American Medical Association Administrative Costs Associated with Physician Billing and Insurance-Related... View Details
Keywords: Sean Silverthorne
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 08 Jan 2020
- Research & Ideas
NFL Head Coaches Are Getting Younger. What Can Organizations Learn?
three years of fast food experience. By contrast, Torres continues, incumbent C-level exes are “overly focused on internal issues and opt to invest in familiar technologies rather than taking bold risks.”... View Details
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
April 2018 Management Science Offline Showrooms in Omni-channel Retail: Demand and Operational Benefits By: Bell, David R., Santiago Gallino, and Antonio Moreno Abstract—Omnichannel environments where... View Details
Keywords: Sean Silverthorne
- 14 Jul 2020
- Research & Ideas
Restarting Under Uncertainty: Managerial Experiences from Around the World
international cosmetic manufacturer based in France decided to support its 100,000+ clients—salons—across Western Europe to help them survive through the first phases of the COVID-19 crisis. The support included financial, operational, HR, View Details
- 01 Jun 2002
- News
Up to the Challenge: Lori Schock - Listen and Learn
insists, “it's theirs.” One opinion that was heard loud and clear during Schock's SA service was a call for a new prescription drug plan for HBS students. Schock was among student leaders who met with... View Details
Keywords: Kathleen Brill
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
Number one, understand that this vaccine that's being approved is not like other approved drugs from the US Food and Drug Administration. Usually... View Details
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say... View Details
- January 2020
- Article
The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System
By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details
Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
- December 2022
- Article
'Just Letting You Know…': Underestimating Others' Desire for Constructive Feedback
By: Nicole Abi-Esber, Jennifer E. Abel, Juliana Schroeder and Francesca Gino
People often avoid giving feedback to others even when it would help fix a problem immediately. Indeed, in a pilot field study (N=155), only 2.6% of individuals provided feedback to survey administrators that the administrators had food or marker on their faces.... View Details
Keywords: Feedback; Helping; Prosocial Behavior; Misprediction; Relationships; Interpersonal Communication; Perspective
Abi-Esber, Nicole, Jennifer E. Abel, Juliana Schroeder, and Francesca Gino. "'Just Letting You Know…': Underestimating Others' Desire for Constructive Feedback." Journal of Personality and Social Psychology 123, no. 6 (December 2022): 1362–1385.
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords: Digital; Medicine; FDA; Health Care and Treatment; Applications and Software; Safety; Cybersecurity; Medical Devices and Supplies Industry
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive... View Details
- January 2016 (Revised July 2018)
- Case
Cyberdyne: A Leap to the Future
By: Doug J. Chung and Mayuka Yamazaki
Cyberdyne Inc. was a Japanese technology venture that wanted to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from stroke, spinal cord injury (SCI),... View Details
Keywords: Go-to-market Strategy; Pricing; Sales Channel; Technological Innovation; Marketing; Sales; Distribution; Strategy; Medical Devices and Supplies Industry
Chung, Doug J., and Mayuka Yamazaki. "Cyberdyne: A Leap to the Future." Harvard Business School Case 516-072, January 2016. (Revised July 2018.)
- 08 Nov 2016
- First Look
November 8, 2016
foods, which had previously been colored with dyes extracted from natural plants and organic minerals, helping them to achieve mass production and mass marketing. Color was easier to control, reproduce,... View Details
Keywords: Sean Silverthorne
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs... View Details